Curated By Isabella Tang
Despite significant investments in artificial intelligence, Chinese models are unlikely to surpass their Western counterparts, according to the CEO of Qwen. The statement comes in the wake of a $1 billion AI IPO in China, highlighting the challenges the nation faces in the global AI race.
In response to the ongoing investigation into Jane Street's trading practices in India, Chinese regulators are scrutinizing foreign exchange-traded funds (ETFs) that involve domestic investors. This move highlights China's increasing vigilance over foreign financial activities within its borders.
China is rapidly closing the technological gap with the United States, particularly in artificial intelligence research, according to recent findings. Experts suggest that despite facing various constraints, China's innovations are reshaping the global tech landscape.
Bob Iger's recent meeting with China's Vice Premier Ding Xuexiang has sparked fresh speculation about the possibility of a third Disney park in China. This development could significantly impact the entertainment landscape in the region, as Disney continues to expand its global footprint.
Chinese AI startups are navigating a complex landscape as they aim for public listings, facing heightened regulatory scrutiny and market volatility. This situation presents both challenges and opportunities for the burgeoning tech sector in China.
Chinese startups are increasingly turning to public offerings as the demand for artificial intelligence technologies surges. This trend marks a significant moment in the Chinese tech landscape, reflecting both opportunities and challenges.
Smart Logistics Global Limited has announced the establishment of a new Northern Supply Chain Center in Xuzhou, aimed at enhancing its logistics capabilities across Mainland China. This strategic move is expected to bolster the company's nationwide network and improve service efficiency.
HUTCHMED has initiated a Phase III clinical trial to evaluate the efficacy of a combination therapy involving Surufatinib and Camrelizumab for treatment-naïve patients with pancreatic ductal adenocarcinoma. This trial marks a significant step in the fight against one of the most aggressive forms of cancer in Mainland China.
HUTCHMED has announced the initiation of a Phase III clinical trial for the combination therapy of Surufatinib and Camrelizumab aimed at treating pancreatic ductal adenocarcinoma. This trial represents a significant step forward in the fight against one of the most aggressive forms of cancer.
As the world grapples with post-pandemic recovery, China's economic resurgence is a focal point of discussion. This report explores the factors driving China's growth and its implications for global markets.
China faces numerous challenges, but its resilience and adaptability are evident in various sectors. This report explores how the nation is leveraging its strengths to overcome obstacles and maintain growth.
A recent study highlights the alarming prevalence of depression symptoms among empty-nest elderly in China, revealing significant influencing factors. As the demographic landscape shifts, understanding and addressing mental health in this vulnerable group becomes increasingly critical.
As the tech war intensifies, China is making significant strides in artificial intelligence development. The country's focus on innovation is set to reshape the global landscape of technology in 2026 and beyond.
In 2026, China is poised to make significant advancements in artificial intelligence, showcasing its commitment to becoming a global leader in AI technology. This report explores the strategies and developments driving China's AI innovation forward.
As China accelerates its artificial intelligence development, the nation aims to position itself as a leader in AI technology by 2026. This ambitious strategy is expected to reshape various industries and enhance China's global competitiveness.
President Xi Jinping highlights China's rapid economic growth and innovation capabilities in a recent address. The remarks underscore China's ambition to solidify its position as a global economic powerhouse.
Despite a prolonged slump in the property sector, China's economy shows signs of resilience, driven by consumer spending and government initiatives. Analysts suggest that while challenges remain, the overall economic outlook is cautiously optimistic.
HUTCHMED has announced the acceptance of its New Drug Application (NDA) for Savolitinib in China, receiving priority review status for treating gastric cancer patients with MET amplification. This significant milestone could enhance treatment options for a critical patient demographic in the region.
Meta's Manus, a tech venture originally based in China, will sever ties with Chinese investors and cease all operations in the country. This decision comes in response to increasing regulatory pressures and a shifting business landscape in China.
Shenzhen's newly developed economic zone, built on reclaimed land, symbolizes China's commitment to economic reform and opening up to global markets. This initiative aims to attract foreign investment and foster innovation, showcasing Shenzhen's role as a leading city in China's economic landscape.
In a significant move against corruption within its ranks, the Chinese military has expelled three high-ranking officials. This action underscores the ongoing anti-corruption campaign led by President Xi Jinping.
Hainan's Free Trade Port (FTP) has initiated comprehensive customs operations aimed at enhancing trade efficiency and regulatory compliance. This move is expected to streamline processes and bolster the region's economic development.
In 2025, China continues to position itself as a pivotal player in the global economy, sharing growth dividends and opportunities with the world. The country's commitment to sustainable development and innovation is reshaping its role on the international stage.
In 2025, China has emerged as a pivotal player in the global economy, sharing growth dividends and opportunities with the world. This report delves into how China's economic strategies are shaping its role as an empowering nation.
